TNDM logo

Tandem Diabetes Care (TNDM) EBITDA

annual EBITDA:

-$69.75M+$126.71M(+64.49%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TNDM annual EBITDA is -$69.75 million, with the most recent change of +$126.71 million (+64.49%) on December 31, 2024.
  • During the last 3 years, TNDM annual EBITDA has fallen by -$103.81 million (-304.80%).
  • TNDM annual EBITDA is now -304.80% below its all-time high of $34.06 million, reached on December 31, 2021.

Performance

TNDM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNDMincome statement metrics

quarterly EBITDA:

-$116.42M-$120.64M(-2862.06%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TNDM quarterly EBITDA is -$116.42 million, with the most recent change of -$120.64 million (-2862.06%) on March 31, 2025.
  • Over the past year, TNDM quarterly EBITDA has dropped by -$82.36 million (-241.85%).
  • TNDM quarterly EBITDA is now -565.85% below its all-time high of $24.99 million, reached on December 31, 2020.

Performance

TNDM quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNDMincome statement metrics

TTM EBITDA:

-$152.59M-$82.36M(-117.29%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TNDM TTM EBITDA is -$152.59 million, with the most recent change of -$82.36 million (-117.29%) on March 31, 2025.
  • Over the past year, TNDM TTM EBITDA has dropped by -$41.63 million (-37.53%).
  • TNDM TTM EBITDA is now -452.34% below its all-time high of $43.31 million, reached on September 30, 2021.

Performance

TNDM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTNDMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TNDM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.5%-241.8%-37.5%
3 y3 years-304.8%-892.3%-765.6%
5 y5 years-276.4%-799.8%-1440.0%

TNDM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-304.8%+64.5%-2862.1%+2.2%-765.6%+24.4%
5 y5-year-304.8%+64.5%-565.9%+2.2%-452.3%+24.4%
alltimeall time-304.8%+64.5%-565.9%+2.2%-452.3%+24.4%

TNDM EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$116.42M(-2862.1%)
-$152.59M(+117.3%)
Dec 2024
-$69.75M(-64.5%)
$4.21M(-125.5%)
-$70.22M(-29.8%)
Sep 2024
-
-$16.54M(-30.6%)
-$100.00M(-5.7%)
Jun 2024
-
-$23.84M(-30.0%)
-$106.03M(-4.4%)
Mar 2024
-
-$34.06M(+33.2%)
-$110.95M(-43.4%)
Dec 2023
-$196.46M(+164.7%)
-$25.57M(+13.3%)
-$195.90M(+7.8%)
Sep 2023
-
-$22.57M(-21.5%)
-$181.72M(-10.0%)
Jun 2023
-
-$28.76M(-75.8%)
-$201.92M(+11.3%)
Mar 2023
-
-$119.00M(+944.4%)
-$181.48M(+144.6%)
Dec 2022
-$74.21M(-317.9%)
-$11.39M(-73.4%)
-$74.21M(+57.7%)
Sep 2022
-
-$42.76M(+414.0%)
-$47.07M(-882.2%)
Jun 2022
-
-$8.32M(-29.1%)
$6.02M(-73.7%)
Mar 2022
-
-$11.73M(-174.5%)
$22.92M(-32.7%)
Dec 2021
$34.06M(-349.0%)
$15.74M(+52.5%)
$34.06M(-21.4%)
Sep 2021
-
$10.33M(+20.3%)
$43.31M(+38.8%)
Jun 2021
-
$8.59M(-1536.0%)
$31.21M(-2436.2%)
Mar 2021
-
-$598.00K(-102.4%)
-$1.34M(-90.2%)
Dec 2020
-$13.68M(-26.2%)
$24.99M(-1512.7%)
-$13.68M(-60.1%)
Sep 2020
-
-$1.77M(-92.6%)
-$34.30M(+1.3%)
Jun 2020
-
-$23.96M(+85.2%)
-$33.87M(+241.9%)
Mar 2020
-
-$12.94M(-396.0%)
-$9.91M(-46.5%)
Dec 2019
-$18.53M(-83.0%)
$4.37M(-425.0%)
-$18.52M(+4.6%)
Sep 2019
-
-$1.34M(<-9900.0%)
-$17.70M(-62.9%)
Jun 2019
-
$5000.00(-100.0%)
-$47.75M(-53.5%)
Mar 2019
-
-$21.55M(-515.7%)
-$102.60M(-6.0%)
Dec 2018
-$109.18M
$5.18M(-116.5%)
-$109.18M(-9.6%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$31.39M(-42.8%)
-$120.73M(+19.9%)
Jun 2018
-
-$54.84M(+95.0%)
-$100.73M(+59.4%)
Mar 2018
-
-$28.13M(+341.4%)
-$63.21M(+15.3%)
Dec 2017
-$54.82M(-24.1%)
-$6.37M(-44.0%)
-$54.82M(-9.1%)
Sep 2017
-
-$11.39M(-34.3%)
-$60.28M(-20.7%)
Jun 2017
-
-$17.32M(-12.3%)
-$75.98M(+2.4%)
Mar 2017
-
-$19.74M(+66.8%)
-$74.22M(+2.7%)
Dec 2016
-$72.27M(+13.2%)
-$11.84M(-56.3%)
-$72.27M(+2.7%)
Sep 2016
-
-$27.08M(+74.0%)
-$70.34M(+15.9%)
Jun 2016
-
-$15.56M(-12.5%)
-$60.68M(-2.9%)
Mar 2016
-
-$17.79M(+79.5%)
-$62.49M(-2.1%)
Dec 2015
-$63.84M(-10.3%)
-$9.91M(-43.1%)
-$63.84M(-8.9%)
Sep 2015
-
-$17.42M(+0.2%)
-$70.09M(-0.6%)
Jun 2015
-
-$17.38M(-9.2%)
-$70.48M(+0.1%)
Mar 2015
-
-$19.13M(+18.3%)
-$70.39M(-1.1%)
Dec 2014
-$71.16M(+28.8%)
-$16.17M(-9.2%)
-$71.16M(-7.3%)
Sep 2014
-
-$17.81M(+3.0%)
-$76.74M(+9.6%)
Jun 2014
-
-$17.29M(-13.1%)
-$70.03M(+6.2%)
Mar 2014
-
-$19.90M(-8.5%)
-$65.95M(+19.3%)
Dec 2013
-$55.26M(+94.2%)
-$21.74M(+95.9%)
-$55.26M(+34.0%)
Sep 2013
-
-$11.10M(-16.0%)
-$41.23M(+14.6%)
Jun 2013
-
-$13.21M(+43.4%)
-$35.97M(+58.0%)
Mar 2013
-
-$9.21M(+19.5%)
-$22.76M(+68.0%)
Dec 2012
-$28.46M(+20.1%)
-$7.71M(+31.9%)
-$13.55M(+131.9%)
Sep 2012
-
-$5.84M
-$5.84M
Dec 2011
-$23.69M
-
-

FAQ

  • What is Tandem Diabetes Care annual EBITDA?
  • What is the all time high annual EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care annual EBITDA year-on-year change?
  • What is Tandem Diabetes Care quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care quarterly EBITDA year-on-year change?
  • What is Tandem Diabetes Care TTM EBITDA?
  • What is the all time high TTM EBITDA for Tandem Diabetes Care?
  • What is Tandem Diabetes Care TTM EBITDA year-on-year change?

What is Tandem Diabetes Care annual EBITDA?

The current annual EBITDA of TNDM is -$69.75M

What is the all time high annual EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high annual EBITDA is $34.06M

What is Tandem Diabetes Care annual EBITDA year-on-year change?

Over the past year, TNDM annual EBITDA has changed by +$126.71M (+64.49%)

What is Tandem Diabetes Care quarterly EBITDA?

The current quarterly EBITDA of TNDM is -$116.42M

What is the all time high quarterly EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high quarterly EBITDA is $24.99M

What is Tandem Diabetes Care quarterly EBITDA year-on-year change?

Over the past year, TNDM quarterly EBITDA has changed by -$82.36M (-241.85%)

What is Tandem Diabetes Care TTM EBITDA?

The current TTM EBITDA of TNDM is -$152.59M

What is the all time high TTM EBITDA for Tandem Diabetes Care?

Tandem Diabetes Care all-time high TTM EBITDA is $43.31M

What is Tandem Diabetes Care TTM EBITDA year-on-year change?

Over the past year, TNDM TTM EBITDA has changed by -$41.63M (-37.53%)
On this page